News

US Health and Human Services Secretary Robert F. Kennedy Jr. has repeatedly claimed in public statements that most vaccines ...
Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with Veterans Affairs exploring treatments that show promise in clinical trials.
Artificial blood could reduce preventable deaths in settings where limited supply costs millions of lives in low-income ...
Only a handful of stem cell therapies are currently approved by the F.D.A., mainly for treating blood cancer and immune ...
Elon Musk’s Neuralink isn’t the only contender in the brain-tech race. Paradromics has entered the arena with its first human brain-computer interface (BCI) implant. The neurotechnology startup on ...
While all groups have demonstrated an inspiring level of dedication and passion, I have always been moved by patients’ ...
He said that this development has raised the hope for controlling the deadly viral disease. NAN reports that Lassa fever is ...
This year marks an important turning point for brain-computer interface development in China as clinical trials get underway.
Neuralink accelerates its brain-computer interface ambitions with a major funding boost and ongoing human trials.
Phase 2 data expected in 2H 2026 - - KPL-387 Phase 1 single ascending dose data support profile for monthly dosing - LONDON, ...
Maxiom Labs, Inc. (MAXIOM) officially launched its revolutionary AI platform designed to optimize health, fitness, and performance-for committed athletes and everyday achievers alike. After months of ...
Elon Musk’s brain-computer interface company, Neuralink, has secured $650 million in a fresh funding round as it moves ahead with ...